These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12506456)

  • 41. Strengthening evaluations of disease state management programs.
    Kozma CM
    Manag Care Interface; 1998 Dec; 11(12):77-8. PubMed ID: 10338746
    [No Abstract]   [Full Text] [Related]  

  • 42. Driving DM with an electronic solution that goes beyond the EMR.
    Dis Manag Advis; 2005 Nov; 11(11):129-32, 121. PubMed ID: 16392687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Make glaucoma screening a routine part of DM programs.
    Healthc Demand Dis Manag; 1998 Apr; 4(4):59-61. PubMed ID: 10178986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pfizer: DM did not fizzle in Florida Medicaid ruckus.
    Carroll J
    Manag Care; 2004 Sep; 13(9):10, 12. PubMed ID: 15490673
    [No Abstract]   [Full Text] [Related]  

  • 45. Improving patient-clinician communication about chronic conditions: description of an internet-based nurse E-coach intervention.
    Allen M; Iezzoni LI; Huang A; Huang L; Leveille SG
    Nurs Res; 2008; 57(2):107-12. PubMed ID: 18347482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Putting MS patients back in control. Interview by Nicola O'Connell.
    Gutteridge V
    Nurs Times; 2006 Aug 15-21; 102(33):20-1. PubMed ID: 16937732
    [No Abstract]   [Full Text] [Related]  

  • 47. Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.
    Girouard N; Théorêt G
    Can J Neurosci Nurs; 2008; 30(4):18-25. PubMed ID: 19146204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consultant: CM must move to DM model.
    Hosp Case Manag; 2007 Oct; 15(10):157-9. PubMed ID: 17955896
    [No Abstract]   [Full Text] [Related]  

  • 49. Ten-city disease management project intended to increase wellness efforts.
    Fine A
    Manag Care Q; 2006; 14(1):20-1. PubMed ID: 17590973
    [No Abstract]   [Full Text] [Related]  

  • 50. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
    Kros JF; Molis J
    Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
    [No Abstract]   [Full Text] [Related]  

  • 51. Use the Internet to enhance disease management and reduce costs under capitation.
    Capitation Manag Rep; 2001 Mar; 8(3):39-40, 33. PubMed ID: 11299641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opportunities for administrators to promote disease management.
    Kash BA; Gamm LD; Bolin JN; Peck BM
    J Healthc Manag; 2005; 50(5):297-309; discussion 309-10. PubMed ID: 16268409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. For pharmaceutical companies, a data warehouse can be just what the doctor ordered.
    Desai A
    Health Manag Technol; 1999 Mar; 20(2):20-2. PubMed ID: 10346471
    [No Abstract]   [Full Text] [Related]  

  • 54. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Web-based patient management tool and collaborative quality improvement boost heart disease guideline compliance.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Feb; 15(4):7-9. PubMed ID: 15000098
    [No Abstract]   [Full Text] [Related]  

  • 56. The costs of compliance.
    Leeman E
    J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):179-87. PubMed ID: 17650971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New approach seeks to conquer physician resistance to DM.
    Dis Manag Advis; 2002 Jan; 8(1):1-5. PubMed ID: 11842663
    [No Abstract]   [Full Text] [Related]  

  • 58. Helping people come to terms with MS.
    Hayes G
    Nurs Times; 2003 Oct 28-Nov 3; 99(43):46-7. PubMed ID: 14626047
    [No Abstract]   [Full Text] [Related]  

  • 59. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
    Lugaresi A
    Expert Opin Drug Deliv; 2009 Sep; 6(9):995-1002. PubMed ID: 19637982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tolerability, adherence, and patient outcomes.
    Ross AP
    Neurology; 2008 Dec; 71(24 Suppl 3):S21-3. PubMed ID: 19064871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.